59 results
8-K
EX-4.1
PHAT
Phathom Pharmaceuticals, Inc.
19 Aug 24
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
5:13pm
organization, any other entity and a government or any department or agency thereof. “Principal Trading Market” means the national securities exchange
8-K
EX-1.1
PHAT
Phathom Pharmaceuticals, Inc.
19 Aug 24
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
5:13pm
administered or enforced by the U.S. Government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department … of the Treasury, or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or “blocked person
8-K
EX-99.1
PHAT
Phathom Pharmaceuticals, Inc.
19 Aug 24
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
5:13pm
Syndicate Department, 330 Madison Avenue, 8th floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery
424B5
PHAT
Phathom Pharmaceuticals, Inc.
19 Aug 24
Prospectus supplement for primary offering
5:12pm
and is subject to the diligence and reporting requirements in clause (1) above, it must enter into an agreement with the U.S. Department of the Treasury
FWP
l11kk0q0gv1fymc7
19 Aug 24
Free writing prospectus
6:05am
8-K
EX-1.1
t1vf1tcy29jk
24 May 23
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:14pm
8-K
EX-99.2
2lwjnx
24 May 23
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:14pm
8-K
EX-99.1
izpgqs7mvdw3vis
24 May 23
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:14pm
424B5
4uzuxbu 4z
24 May 23
Prospectus supplement for primary offering
4:11pm
424B5
gby7 e4c3vi8y5w
23 May 23
Prospectus supplement for primary offering
4:47pm
PRE 14A
e9yi5yf
31 Mar 23
Preliminary proxy
4:06pm